Abbott (ticker: ABT, exchange: New York Stock Exchange (.N))
News Release -
Abbott Laboratories Names Executives to Lead U.S. Pharmaceutical And International BusinessesABBOTT PARK, Ill., Mar 14, 2003 /PRNewswire-FirstCall via COMTEX/ -- Abbott
Laboratories (NYSE: ABT) today announced that William G. Dempsey has been named
senior vice president, pharmaceutical operations, for Abbott's U.S.
pharmaceutical business. Guillermo A. Herrera has been named senior vice
president, international operations, and replaces Dempsey who held the position
since 1999. The appointments are effective immediately.
Both Dempsey and Herrera will report to Jeffrey M. Leiden, M.D., Ph.D.,
president and chief operating officer, Pharmaceutical Products Group, Abbott
Dempsey, 51, joined Abbott in 1982. He most recently served as senior vice
president, international operations, and led the highly successful integration
of BASF's pharmaceutical business, which included the global operations of
Knoll. Dempsey has spent over 20 years at Abbott and has held a number of
management positions. He holds a bachelor's degree in accounting from DePaul
Since June 2001, Herrera, 49, has served as vice president, European operations
for Abbott's international division. He has more than 20 years of Abbott service
and has held various managerial positions in the company's international
division including vice president, Latin America and Canada. Herrera earned a
bachelor's degree in industrial economics from Universidad del Valle in
Colombia, South America, and a master's degree in business administration from
Northwestern University's Kellogg Graduate School of Management.
"Bill Dempsey and Guillermo Herrera are experienced Abbott leaders with a
long-standing history of excellent performance and results," Miles D. White,
Abbott's chairman and chief executive officer, said. "We're fortunate to have
Bill and Guillermo to lead these businesses as we begin to launch significant
products emerging from our pipeline."
Abbott Laboratories is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals,
nutritionals, and medical products, including devices and diagnostics. The
company employs more than 70,000 people and markets its products in more than
130 countries. In 2002, the company's sales and net earnings were $17.7 billion
and $3.2 billion, respectively, with diluted earnings per share of $2.06,
excluding one-time charges.
Abbott's news releases and other information are available on the company's Web
site at www.abbott.com .
SOURCE Abbott Laboratories
CONTACT: Media, Melissa Brotz, +1-847-935-3456, or Kathleen Gilgunn,
+1-847-938-3895, or Financial Community, John Thomas, +1-847-938-2655, all of
/Company News On-Call: http://www.prnewswire.com/comp/110328.html
Copyright (C) 2003 PR Newswire. All rights reserved.